0RR Stock Overview
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Venus Concept Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.15 |
| 52 Week High | US$11.10 |
| 52 Week Low | US$1.99 |
| Beta | 0.97 |
| 1 Month Change | 0% |
| 3 Month Change | -6.25% |
| 1 Year Change | -62.50% |
| 3 Year Change | -91.92% |
| 5 Year Change | n/a |
| Change since IPO | -92.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0RR | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | 4.0% | 2.0% |
| 1Y | -62.5% | -8.3% | 2.0% |
Return vs Industry: 0RR underperformed the German Medical Equipment industry which returned -2.5% over the past year.
Return vs Market: 0RR underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| 0RR volatility | |
|---|---|
| 0RR Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 0RR's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 0RR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 384 | Rajiv Kanishka De Silva | www.venus.ai |
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system.
Venus Concept Inc. Fundamentals Summary
| 0RR fundamental statistics | |
|---|---|
| Market cap | €9.39m |
| Earnings (TTM) | -€40.85m |
| Revenue (TTM) | €85.49m |
0.1x
P/S Ratio-0.2x
P/E RatioIs 0RR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0RR income statement (TTM) | |
|---|---|
| Revenue | US$93.62m |
| Cost of Revenue | US$31.72m |
| Gross Profit | US$61.91m |
| Other Expenses | US$106.65m |
| Earnings | -US$44.74m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Aug 14, 2023
| Earnings per share (EPS) | -8.10 |
| Gross Margin | 66.12% |
| Net Profit Margin | -47.79% |
| Debt/Equity Ratio | -37,590.8% |
How did 0RR perform over the long term?
See historical performance and comparison